Buyer for early-stage Contract Research Organisation in Europe

Bedrijf gevraagd

• Grootte: Middelgroot bedrijf
• Omzet: 2-20 M EUR
• Locatie van het doelbedrijf: Europa
• CFIE PHB329

Overview of buyer for early-stage Contract Research Organisation in Europe

A globally recognized specialist Contract Research Organization (CRO) is seeking to expand through the acquisition of early-stage CROs in Europe. As the world leader in human challenge trials, this organization focuses on testing infectious and respiratory disease vaccines and therapeutics, providing end-to-end early clinical development services to a diverse, international client base of pharmaceutical and biotechnology companies.

Profile of buyer for early-stage Contract Research Organisation in Europe

With a rich legacy of over two decades in conducting human challenge studies, the company has built a reputation for scientific excellence and operational innovation. It operates from multiple state-of-the-art facilities designed to deliver high-quality, compliant, and efficient clinical trial experiences. The organization’s mission is to empower innovation in healthcare and transform the drug development process through cutting-edge science and a future-focused vision.

Activity and Products of buyer for early-stage Contract Research Organisation in Europe

This CRO specializes in human challenge trials across a portfolio of 11+ challenge models including Influenza, RSV, HRV, Asthma, Cough, COPD, COVID-19, hMPV, and Malaria. It offers full-spectrum services tailored to the needs of pharmaceutical and biotech sponsors, ensuring strategic and effective early-phase clinical development. Additionally, the company operates a highly specialized virology and immunology laboratory that supports both pre-clinical and clinical respiratory drug and vaccine development. Its labs deliver precise, submission-ready data supported by rigorous scientific and quality standards.

Highlights of buyer for early-stage Contract Research Organisation in Europe

• Global leader in human challenge trial research with over 25 years of experience
• Operates the largest dedicated human challenge trial facility in the world, equipped with advanced laboratories and high-capacity quarantine units
• Offers a broad range of challenge study models and laboratory services, supporting diverse clinical and pre-clinical development needs
• Maintains multiple strategically located screening and recruitment sites for optimized participant enrollment
• Backed by a team of highly skilled scientists and clinicians, underpinned by a mission to revolutionize healthcare through scientific ingenuity

Meer informatie over: Buyer for early-stage Contract Research Organisation in Europe

Neem gerust contact met ons op als u meer wilt weten over: Buyer for early-stage Contract Research Organisation in Europe. Voor meer CRO-bedrijven te koop, bezoek CRO-bedrijven te koop. Voor andere CRO-kopers, bezoek CRO-bedrijven gevraagd. Als u in plaats daarvan geïnteresseerd bent in farmaceutische bedrijven te koop, bezoek farmaceutische bedrijven te koop . Voor farmaceutische kopers, bezoek farmaceutische bedrijven gevraagd.